Debut Plus

28.92

-0.31 -1.06%

17 Jul 2026

BSE Listed

GSM 0 · ESM 1

Prism Medico And Pharmacy (512217)

Volume: 1,360Avg Vol 1W: 1,717Avg Vol 1M: 5,32952W Range:12.4934.49
Key Ratios
Checked 7h ago
Market Cap₹40 Cr
Current Price₹28.92
Previous Close₹29.23
High / Low (52w)₹34.49 / ₹12.49
Volume1,360
Avg Vol (1W)1,717
Avg Vol (1M)5,329
Stock P/E127.04
Book Value₹16.89
Dividend Yield0%
ROE206.6%
ROA211.4%
Revenue (TTM)
Revenue Growth
Profit Margin13.52%
Total Debt
Shares Outstanding1 Cr
Face Value
EPS (TTM)₹0.23
P/B1.73
Debt / Equity0.17
50 DMA₹28.83
200 DMA₹23.55
Day change-1.06%
SurveillanceGSM 0 · ESM 1 (as of 2026-07-17)
Price Chart
28.92 103.95% · 1Y
34138.4L
2025-07-17
2026-07-17

20-day avg volume: 4K shares

Pros
  • Healthy return on equity of 206.6%.
  • Company is almost debt-free.
  • Revenue grew 140% YoY.
Cons
  • Stock trades at a high P/E of 127.
Quarterly Results
MetricMar 2018Jun 2018Sept 2018Dec 2018Mar 2019Jun 2019Sept 2019Dec 2019
Revenue₹0 Cr₹6 Cr₹15 Cr₹17 Cr₹17 Cr₹9 Cr₹7 Cr₹10 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹-1 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹-1 Cr₹0 Cr₹0 Cr₹0 Cr
EPS
Profit & Loss (Annual)
MetricMar 2017Mar 2018Mar 2019
Revenue₹5 Cr₹23 Cr₹55 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr
EPS-0.36-0.010.07
Balance Sheet
MetricMar 2017Mar 2018Mar 2019
Total Assets₹17 Cr₹16 Cr₹21 Cr
Total Liabilities₹4 Cr₹3 Cr₹8 Cr
Equity₹13 Cr₹13 Cr₹13 Cr
Total Debt
Cash Flow
MetricMar 2018Mar 2019
Operating₹4 Cr₹0 Cr
Investing₹-3 Cr₹0 Cr
Financing₹-2 Cr₹-1 Cr
Free Cash Flow₹4 Cr₹0 Cr
Shareholding
Promoter 30.2% Institutions 0% Public 69.8%
Efficiency & Working Capital
ROCE2.8%
Interest Coverage2.2
Dividend Payout
Debtor Days21 d
Inventory Days9 d
Payable Days39 d
Cash Conversion Cycle-8 d
Working Capital Days30 d
Shareholding Details

As of 2026-05-31

Promoter30.2%
FII0%
DII0%
Institutions0%
Public69.8%
Promoter Pledge0%
No. of Shareholders4,300
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026May 2026
Promoters25%25%25%25%25%25%25%25%25%25%25.5%30.2%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public75%75%75%75%75%75%75%75%75%75%74.5%69.8%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders3,4653,6503,7923,8664,1074,1784,3024,3064,3154,3064,2954,300
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503
Major Shareholders (>1%)
NameCategoryStakeShares
Dharmender KharbPublic Shareholding19.4%26,25,000
Symbiosis Pharmaceutical Private LimitedShareholding of Promoter and Promoter Group15.7%21,23,083
Galaxy Vitacare Private LimitedShareholding of Promoter and Promoter Group13.3%17,97,672
Raju TyagiPublic Shareholding9.8%13,25,000
Sejal S NashatarPublic Shareholding2.5%3,40,000
Harsh Jentibhai RupareliyaPublic Shareholding2.4%3,30,000
Shilpa Harsh RupareliyaPublic Shareholding2.4%3,30,000
Bosco Armando MenezesPublic Shareholding1.1%1,50,000
Emily Bosco MenezesPublic Shareholding1.1%1,50,000
Ramit WaliaShareholding of Promoter and Promoter Group1.1%1,45,106
Reeta DeviPublic Shareholding1%1,39,740
Jasjot SinghShareholding of Promoter and Promoter Group0.2%30,000
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Ramit Walia00%2026-05-05
Jasjot Singh00%2026-05-05
Symbiosis Pharmaceutical Private Limited00%2026-05-05
Galaxy Vitacare Private Limited00%2026-05-05
Bosco Armando Menezes00%2026-05-05
Reeta Devi00%2026-05-05
Emily Bosco Menezes00%2026-05-05
Sejal S Nashatar00%2026-05-05
Harsh Jentibhai Rupareliya00%2026-05-05
Shilpa Harsh Rupareliya00%2026-05-05
Raju Tyagi00%2026-05-05
Dharmender Kharb00%2026-05-05
Board of Directors
NameDesignationYear
Sakshi LallerWhole-time Director2025
Davender SinghDirector2025
DINESH KUMARIndependent Non Exe. Director2025
Pradeep KumarIndependent Non Exe. Director2025
Sameer GuptaCompany Sec. & Compli. Officer2025
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹102566
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202500003
2025000011
2025000011
Substantial Acquisitions (SAST)

6 disclosure(s)

Market18/08/2021 · 22,165
Market12/08/2021 · 11,320
Market06/08/2021 · 25,000
Market26/07/2021 - 27/07/2021 · 65,000
Market23/07/2021 · 2,500
Market22/07/2021 · 85,000
Company Information
Incorporated2002
AuditorHarjeet Parvesh & Co
Investor Email[email protected]
🌐 www.prismmedico.in

📍 D-118 Industrial Area, Phase VII, Mohali, Punjab, 160055

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search